FindTrial
Sign In

Hs CRP level in pre eclampsia

STUDY OF HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) LEVELS IN EARLY AND LATE ONSET PRE ECLAMPSIA IN A TERTIARY CARE HOSPITAL - ONE YEAR CROSS SECTIONAL STUDY - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065086
Enrollment
96
Registered
2024-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O140- Mild to moderate pre-eclampsia

Interventions

Control Intervention1: Nil: Nil

Sponsors

Chintakindi Preethi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All preeclamptic pregnant women who are admitted in antenatal ward or labour room 2. Singleton pregnancy 3. Pre eclamptic women willing to participate in the study

Exclusion criteria

Exclusion criteria: 1. Preeclamptic women with history of fever or recent infections or who are receiving antibiotic treatment or steroids. 2. Preeclamptic women in labour or presenting with PROM or clinical chorioamnionitis. 3. Preeclamptic women with chronic inflammatory disorders like arthritis, inflammatory bowel disorders, SLE etc. 4. Preeclamptic women with medical disorders (Diabetes mellitus, hepatic disorders, renal disorders) 5. Pregnant women whose BMI > 25kg/m2

Design outcomes

Primary

MeasureTime frame
To study high sensitive c reactive protein levels in early onset pre ecclampsia and late onset pre ecclampsia in pregnancyTimepoint: 20 weeks - 40 weeks—

Secondary

MeasureTime frame
Fetomaternal outcome in raised hsCRP LevelsTimepoint: 1 month—

Countries

India

Contacts

Public ContactChintakindi Preethi

JNMC, KLE University

drdevim30@gmail.com9880515045

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026